Application 050725
- Type
- NDA
- Sponsor
- NEOPHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AUGMENTIN '200' | AMOXICILLIN; CLAVULANATE POTASSIUM | FOR SUSPENSION;ORAL | 200MG/5ML;EQ 28.5MG BASE/5ML | Yes | No |
| 002 | AUGMENTIN '400' | AMOXICILLIN; CLAVULANATE POTASSIUM | FOR SUSPENSION;ORAL | 400MG/5ML;EQ 57MG BASE/5ML | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050725-001 | AUGMENTIN '200' | AMOXICILLIN; CLAVULANATE POTASSIUM | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | |
| N050725-002 | AUGMENTIN '400' | AMOXICILLIN; CLAVULANATE POTASSIUM | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N050725-001 | AUGMENTIN '200' | 200MG/5ML;EQ 28.5MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N050725-002 | AUGMENTIN '400' | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION / ORAL | RLD | 1996-05-31 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| amoxicillin and clavulanate potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Proficient Rx LP | 1f252ad3-373c-4a6d-96e7-53ba820d201b | 2019-11-01 | Warnings, Adverse reactions | 050725 NDA050725 63187-320 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 43598-208 | amoxicillin and clavulanate potassium | amoxicillin and clavulanate potassium | Dr. Reddy's Laboratories Inc | NDA | Current |
| 43598-213 | amoxicillin and clavulanate potassium | amoxicillin and clavulanate potassium | Dr. Reddy's Laboratories Inc | NDA | Current |
| 63187-320 | amoxicillin and clavulanate potassium | amoxicillin and clavulanate potassium | Proficient Rx LP | NDA | Current |
| 63187-320 | amoxicillin and clavulanate potassium | amoxicillin and clavulanate potassium | Proficient Rx LP | NDA | Current |
| 68788-9745 | amoxicillin and clavulanate potassium | amoxicillin and clavulanate potassium | Preferred Pharmaceuticals, Inc. | NDA | Current |
| 70518-2082 | AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | REMEDYREPACK INC. | NDA | Current |
| 70518-2082 | AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | REMEDYREPACK INC. | NDA | Current |
| 72508-204 | AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | Neopharma Inc | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 78374 | SUPPL | 2024-05-02 |
| 78367 | SUPPL | 2024-05-02 |
| 71949 | SUPPL | 2022-08-29 |
| 71931 | SUPPL | 2022-08-26 |
| 30389 | SUPPL | 2013-01-24 |
| 30388 | SUPPL | 2013-01-24 |
| 18132 | SUPPL | 2013-01-23 |
| 18131 | SUPPL | 2013-01-23 |
| 8127 | SUPPL | 2011-10-04 |
| 18130 | SUPPL | 2011-09-30 |
| 30386 | SUPPL | 2008-12-11 |
| 18129 | SUPPL | 2008-12-08 |
| 30387 | SUPPL | 2008-04-02 |
| 39201 | SUPPL | 2008-03-27 |
| 42707 | SUPPL | 2006-10-25 |
| 42706 | SUPPL | 2006-10-25 |
| 42705 | SUPPL | 2006-10-25 |
| 42704 | SUPPL | 2006-10-25 |
| 42703 | SUPPL | 2006-10-25 |
| 42702 | SUPPL | 2006-10-25 |
| 42701 | SUPPL | 2006-10-25 |
| 42700 | SUPPL | 2006-10-25 |
| 22209 | SUPPL | 2006-10-25 |
| 22208 | SUPPL | 2006-10-25 |
| 22207 | SUPPL | 2006-10-25 |
| 22206 | SUPPL | 2006-10-25 |
| 22205 | SUPPL | 2006-10-25 |
| 8126 | SUPPL | 2004-08-12 |
| 8125 | SUPPL | 2004-06-07 |
| 30384 | SUPPL | 2004-05-27 |
| 30385 | SUPPL | 2003-06-08 |